These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 18936885

  • 1. Vaginal microbicides: where are we and where are we going?
    Moscicki AB.
    J Infect Chemother; 2008 Oct; 14(5):337-41. PubMed ID: 18936885
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Specific microbicides in the prevention of HIV infection.
    Kelly CG, Shattock RJ.
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preparing for efficacy trials of vaginal microbicides in Indian women.
    Joshi S, Solomon S, Mayer K, Mehendale S.
    Indian J Med Res; 2005 Apr; 121(4):502-9. PubMed ID: 15817959
    [Abstract] [Full Text] [Related]

  • 11. User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.
    Morrow KM, Underhill K, van den Berg JJ, Vargas S, Rosen RK, Katz DF.
    Arch Sex Behav; 2014 Oct; 43(7):1459-67. PubMed ID: 24452632
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A summary of preclinical topical microbicide vaginal safety and chlamydial efficacy evaluations in a pigtailed macaque model.
    Patton DL, Cosgrove Sweeney YT, Paul KJ.
    Sex Transm Dis; 2008 Oct; 35(10):889-97. PubMed ID: 18607310
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.
    Herold BC, Mesquita PM, Madan RP, Keller MJ.
    Am J Reprod Immunol; 2011 Mar; 65(3):325-33. PubMed ID: 21143689
    [Abstract] [Full Text] [Related]

  • 16. The design of prophylactic trials for HIV: the case of microbicides.
    Stein ZA, Myer L, Susser M.
    Epidemiology; 2003 Jan; 14(1):80-3; discussion 83-4. PubMed ID: 12500050
    [No Abstract] [Full Text] [Related]

  • 17. Twice-daily application of HIV microbicides alter the vaginal microbiota.
    Ravel J, Gajer P, Fu L, Mauck CK, Koenig SS, Sakamoto J, Motsinger-Reif AA, Doncel GF, Zeichner SL.
    mBio; 2012 Dec 18; 3(6):. PubMed ID: 23249810
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR, Kiser PF.
    Antiviral Res; 2013 Sep 18; 99(3):391-400. PubMed ID: 23845918
    [Abstract] [Full Text] [Related]

  • 20. Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents.
    Milligan GN, Dudley KL, Bourne N, Reece A, Stanberry LR.
    Sex Transm Dis; 2002 Oct 18; 29(10):597-605. PubMed ID: 12370527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.